[Individualization of antiviral treatment of chronic hepatitis]

Eksp Klin Gastroenterol. 2013:(6):29-34.
[Article in Russian]
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Caproates / administration & dosage
  • Caproates / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepacivirus / isolation & purification
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / immunology
  • Hepatitis C, Chronic / pathology
  • Hepatitis C, Chronic / virology
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use*
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Liver / pathology
  • Liver / virology
  • Male
  • Middle Aged
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / therapeutic use*
  • Precision Medicine / methods*
  • RNA, Viral / genetics
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Ribavirin / administration & dosage
  • Ribavirin / therapeutic use*
  • Treatment Outcome
  • Virus Replication / drug effects
  • Young Adult

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Caproates
  • Imidazoles
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • pentanedioic acid imidazolyl ethanamide
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b